Biotech | August 09, 2021
Novavax and Serum Institute submits Emergency Use Authorisation of vaccine to regulatory agencies in India, Indonesia and the Philippines
Filing for WHO Emergency Use Authorisation this month
Filing for WHO Emergency Use Authorisation this month
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
The transaction is expected to close in the Q4FY22
Advances deployment of mRNA technology across vaccines and therapeutics development
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
The company has been consistently reducing debt
Deal for 100 million doses with additional 100 million through 2023
Innovative solutions and a deep understanding of the market makes this a unique combination
It is part of the company’s pain/analgesics portfolio of OTC products
Five seats reserved for Wards of COVID warriors in central MBBS admission
Subscribe To Our Newsletter & Stay Updated
